Insoo Suh, M.D. is an Assistant Professor in the UCSF Department of Surgery. He specializes in endocrine surgical diseases of the thyroid, parathyroid, and adrenal glands. Dr. Suh's clinical interests include the application of minimally-invasive techniques such as laparoscopy and robotics to endocrine surgery. His UCSF practice is based at the Comprehensive Cancer Center at Mt. Zion. He also serves as an attending staff surgeon in endocrine surgery at the San Francisco VA Medical Center.
Dr. Suh received a B.S. in Molecular Biophysics & Biochemistry from Yale University, and obtained his M.D. from UCSF. He also completed his surgical residency and endocrine surgery research fellowship at UCSF. He then completed an additional fellowship in surgical innovation from the Stanford University Biodesign Program prior to joining UCSF's faculty.
Dr. Suh has received several awards in recognition of his clinical and research achievements, including the Fred H. and Esther E. Nusz Achievement Award from UCSF, as well as the Basic Science Research Award from the American Association of Endocrine Surgeons. He is an active associate member of several national organizations including the American College of Surgeons and the American Association of Endocrine Surgeons.
Dr. Suh has authored more than 20 peer-reviewed papers, several book chapters, and has served as an invited reviewer for numerous peer-reviewed journals. He is also an inventor of novel medical innovations, with several patent applications to his name and multiple grants (including a current NSF award) to research and develop new technologies.
Kluijfhout WP, Drake FT, Pasternak JD, Beninato T, Mitmaker EJ, Gosnell JE, Shen WT, Suh I, Freise CE, Duh QY. De novo thyroid cancer following solid organ transplantation-A 25-year experience at a high-volume institution with a review of the literature. J Surg Oncol. 2017 Jan 05. View in PubMed
Kluijfhout WP, Beninato T, Drake FT, Vriens MR, Gosnell J, Shen WT, Suh I, Liu C, Duh QY. Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1. World J Surg. 2016 Dec; 40(12):2964-2969. View in PubMed
Beninato T, Kluijfhout WP, Drake FT, Lim J, Kwon JS, Xiong M, Shen WT, Gosnell JE, Liu C, Suh I, Duh QY. Resection of Pheochromocytoma Improves Diabetes Mellitus in the Majority of Patients. Ann Surg Oncol. 2016 Nov 28. View in PubMed
Kluijfhout WP, Pasternak JD, Drake FT, Beninato T, Shen WT, Gosnell JE, Suh I, C L, Duh QY. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine. Surgery. 2016 Nov 14. View in PubMed
Venkatesh S, Pasternak JD, Beninato T, Drake FT, Kluijfhout WP, Liu C, Gosnell JE, Shen WT, Clark OH, Duh QY, Suh I. Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer. Surgery. 2016 Nov 10. View in PubMed
Kluijfhout WP, Venkatesh S, Beninato T, Vriens MR, Duh QY, Wilson DM, Hope TA, Suh I. Performance of magnetic resonance imaging in the evaluation of first-time and reoperative primary hyperparathyroidism. Surgery. 2016 Sep; 160(3):747-54. View in PubMed
Kluijfhout WP, Pasternak JD, Lim J, Kwon JS, Vriens MR, Clark OH, Shen WT, Gosnell JE, Suh I, Duh QY. Frequency of High-Risk Characteristics Requiring Total Thyroidectomy for 1-4?cm Well-Differentiated Thyroid Cancer. Thyroid. 2016 Jun; 26(6):820-4. View in PubMed
Kluijfhout WP, Pasternak JD, Drake FT, Beninato T, Gosnell JE, Shen WT, Duh QY, Allen IE, Vriens MR, de Keizer B, Pampaloni MH, Suh I. Use of PET tracers for parathyroid localization: a systematic review and meta-analysis. Langenbecks Arch Surg. 2016 Apr 16. View in PubMed
Suh I, Yingling C, Randolph GW, Duh QY. A Novel Method of Neuromonitoring in Thyroidectomy and Parathyroidectomy Using Transcutaneous Intraoperative Vagal Stimulation. JAMA Surg. 2016 Mar 1; 151(3):290-2. View in PubMed
Kluijfhout WP, Pasternak JD, Kwon JS, Lim J, Shen WT, Gosnell JE, Khanafshar E, Duh QY, Suh I. Microscopic Positive Tumor Margin Does Not Increase the Risk of Recurrence in Patients with T1-T2 Well-Differentiated Thyroid Cancer. Ann Surg Oncol. 2016 May; 23(5):1446-51. View in PubMed
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.